Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04444921
Title Testing the Addition of Nivolumab to Chemotherapy for Patients With Metastatic Anal Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

anal squamous cell carcinoma

Therapies

Carboplatin + Paclitaxel

Carboplatin + Nivolumab + Paclitaxel

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.